The present invention addresses the problem of providing: a pest repellent that is in a form in which a repellent component is not dissolved in an alcohol-based solvent, and whereby it is possible to maintain a constant repellent effect; and a method for producing the pest repellent. As a solution to this problem, a pest repellent (10) according to the present invention is an oil-in-water emulsion (12) in which a repellent component (14) serves as a dispersoid and water (16) is used as a dispersion medium. In addition, a method for producing the pest repellent (10) according to the present invention is characterized in that the repellent component (14) serves as a dispersoid, water (16) is used as a dispersion medium, and at least one substance selected from vinyl alcohol polymers and copolymers including a vinyl alcohol unit is blended into the oil-in-water emulsion (12) as a dispersion component (18) of the repellent component (14).
A01N 25/30 - Biocides, produits repoussant ou attirant les animaux nuisibles, ou régulateurs de croissance des végétaux, caractérisés par leurs formes, ingrédients inactifs ou modes d'applicationSubstances réduisant les effets nocifs des ingrédients actifs vis-à-vis d'organismes autres que les animaux nuisibles caractérisés par les agents tensio-actifs
A01N 65/24 - Lauraceae [famille du laurier], p. ex. laurier, avocat, sassafras, cannelle ou camphre
An embodiment of the present invention provides a hydrazine-containing waste water treatment method in which hydrazine-containing waste water containing hydrazine and metal ions that are more easily reducible than water is irradiated with light in the presence of a photocatalyst to cause an oxidation reaction of the hydrazine and a reduction reaction of the metal ions. In addition, an embodiment of the present invention provides a hydrazine-containing waste water treatment facility comprising: a reaction tank which can accommodate hydrazine-containing waste water containing hydrazine and metal ions that are more easily reducible than water; and a photocatalyst provided in the reaction tank, wherein the hydrazine-containing waste water treatment facility is capable of irradiating the hydrazine-containing waste water with light in the presence of the photocatalyst to cause an oxidation reaction of the hydrazine and a reduction reaction of the metal ions.
C02F 1/32 - Traitement de l'eau, des eaux résiduaires ou des eaux d'égout par irradiation par la lumière ultraviolette
B01J 23/02 - Catalyseurs contenant des métaux, oxydes ou hydroxydes métalliques non prévus dans le groupe des métaux alcalins ou alcalino-terreux ou du béryllium
B22F 9/24 - Fabrication des poudres métalliques ou de leurs suspensionsAppareils ou dispositifs spécialement adaptés à cet effet par un procédé chimique avec réduction de mélanges métalliques à partir de mélanges métalliques liquides, p. ex. de solutions
C01B 3/04 - Production d'hydrogène ou de mélanges gazeux contenant de l'hydrogène par décomposition de composés inorganiques, p. ex. de l'ammoniac
C02F 1/70 - Traitement de l'eau, des eaux résiduaires ou des eaux d'égout par réduction
C02F 1/72 - Traitement de l'eau, des eaux résiduaires ou des eaux d'égout par oxydation
3.
METHOD FOR PRODUCING COMPOSITE MATERIAL, AND COMPOSITE MATERIAL
This method for producing a composite material comprises: a step for obtaining a mixed liquid by mixing a rubber latex that contains a rubber component, a cellulose nanofiber aqueous dispersion that contains cellulose nanofibers, which each contain a carboxy group, in an aqueous solvent, and an unsaturated carboxylic acid salt that contains at least one of an aluminum ion, a zinc ion and an iron ion; a step for obtaining a first mixture by heating the mixed liquid so as to reduce the water content; a step (S40) for obtaining a second mixture by cleaning the first mixture so as to reduce sodium ions in the first mixture; a step (S50) for obtaining a third mixture by heating the second mixture so as to reduce the water content; and a step (S60) for obtaining a composite material by kneading the third mixture. The cellulose nanofibers include those derived from oxidized cellulose that has been oxidized using an N-oxyl compound.
C08B 15/04 - Carboxycellulose, p. ex. préparée par oxydation avec du peroxyde d'azote
C08J 3/215 - Formation de mélanges de polymères avec des additifs, p. ex. coloration en présence d'une phase liquide le polymère étant prémélangé avec une phase liquide au moins un additif étant également prémélangé avec une phase liquide
C08K 5/098 - Sels métalliques d'acides carboxyliques
Provided is a concentrated winding stator which includes: a winding; a plurality of main poles; and an auxiliary pole, in which the winding is wound around the plurality of main poles, the auxiliary pole is provided between the plurality of main poles, and the stator is configured to increase flux linkage of the winding further than under low load upon the auxiliary pole being magnetically saturated under high load.
[Problem] To provide: paramylon-cellulose mixed fibers having improved water resistance; a nonwoven fabric produced by using the mixed fibers; and a sanitary mask produced by using the nonwoven fabric. [Solution] The present invention solves the problem by providing paramylon-cellulose mixed fibers in which the mass ratio of paramylon to cellulose is set to be in the range of 70:30 to 50:50. In addition, the present invention solves the problem by providing a method for producing paramylon-cellulose mixed fibers, the method including: a spinning dope preparation step for dissolving and mixing cellulose and paramylon in an ionic solution; and a spinning step for discharging the spinning dope obtained in the spinning dope preparation step to a coagulation liquid to form a yarn by a dry-wet spinning method, wherein the sum of the cellulose and the paramylon is 10-30 mass% of the ionic solution, and the mass ratio of the paramylon to the cellulose is in the range of 70:30 to 50:50.
D04H 1/492 - Non-tissés formés uniquement ou principalement de fibres coupées ou autres fibres similaires relativement courtes à partir de voiles ou couches composés de fibres ne possédant pas des propriétés cohésives réelles ou potentielles les voiles ou couches étant renforcées par des moyens mécaniques, p. ex. par roulage par aiguilletage ou opérations similaires pour provoquer l'enchevêtrement des fibres par jet de fluide
To manage health in consideration of the individual difference. An information processing system according to the present invention includes: a measured value storage unit configured to store a measured value linked to a goal to be achieved by a user; an intake storage unit configured to store nutrients intakes of the user; an analysis unit configured to analyze a relationship between the nutrients intake and the measured value to specify nutrients that contribute to improving the measured value (improvement factor) and nutrients that contribute to deteriorating the measured value (deterioration factor); a meal menu storage unit configured to store information specifying the nutrient content in a meal menu; and a meal menu recommendation unit configured to modify the meal menu by at least one of increasing the improvement factor content and decreasing of the deterioration factor content, and recommend the modified meal menu.
G16H 20/60 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant le contrôle de l’alimentation, p. ex. les régimes
Provided is a method for recovering carbon dioxide which includes: a step in which carbon dioxide is brought into contact with an adsorbent capable of adsorbing carbon dioxide to cause the adsorbent to adsorb the carbon dioxide; and a step in which the adsorbent is immersed in a liquid and the carbon dioxide is desorbed from the adsorbent and recovered as a gas phase. The adsorbent has an adsorption of the liquid at 25°C and at a saturated vapor pressure of the liquid of 0.5 mmol/g or larger.
B01D 53/04 - Séparation de gaz ou de vapeursRécupération de vapeurs de solvants volatils dans les gazÉpuration chimique ou biologique des gaz résiduaires, p. ex. gaz d'échappement des moteurs à combustion, fumées, vapeurs, gaz de combustion ou aérosols par adsorption, p. ex. chromatographie préparatoire en phase gazeuse avec adsorbants fixes
A chain transfer agent represented by following general formula (1):
A chain transfer agent represented by following general formula (1):
A chain transfer agent represented by following general formula (1):
In general formula (1), X is a group selected from among a cyano group, an optionally substituted aryl group, an acyl group, a carboxy group, COOR1, C(O)NH2, C(O)NHR1, C(O)NR12, SOR1, SO2R1, SO3R1, and OR1; each Y and Z is a group selected from among a cyano group, an optionally substituted aryl group, an acyl group, a carboxy group, COOR1, C(O)NH2, C(O)NHR1, C(O)NR12, SOR1, SO2R1, SO3R1, OR1, OC(O)R1, N(H)C(O)R1, and a halogen, or Y and Z are bonded to form an optionally substituted carbocyclic structure or an optionally substituted heterocyclic structure; X, Y and Z are the same or different; R1 is an optionally substituted alkyl group having 1 to 8 carbon atoms.
C08J 3/24 - Réticulation, p. ex. vulcanisation, de macromolécules
C07C 69/604 - Esters d'acides polycarboxyliques, dont la partie acide comprend au moins trois groupes carboxyle
C07C 69/618 - Esters d'acides carboxyliques avec un groupe carboxyle lié à un atome de carbone acyclique et comportant un cycle aromatique à six chaînons dans la partie acide avec insaturation autre que celle du cycle aromatique à six chaînons
C07C 255/41 - Nitriles d'acides carboxyliques ayant des groupes cyano liés à des atomes de carbone acycliques ayant des groupes cyano liés à des atomes de carbone acycliques d'un squelette carboné contenant au moins un cycle aromatique à six chaînons le squelette carboné étant substitué de plus par des groupes carboxyle, autres que des groupes cyano
C09J 133/14 - Homopolymères ou copolymères d'esters d'esters contenant des atomes d'halogène, d'azote, de soufre ou d'oxygène en plus de l'oxygène du radical carboxyle
9.
FEED FOR RUMINANTS OBTAINED BY COMBINING METHANE EMISSION INHIBITOR AND LUMEN-PROTECTED AMINO ACID
The objective of the present invention is to provide, for example, a feed enabling effective suppression of methane emission by ruminants. The present invention relates to, for example, a feed for ruminants, which is obtained by combining a methane emission inhibitor and a lumen-protected amino acid.
A23K 50/10 - Produits alimentaires spécialement conçus pour des animaux spécifiques pour les ruminants
A23K 10/37 - Produits alimentaires pour animaux à base de matières d’origine végétale, p. ex. de racines, de graines ou de foinProduits alimentaires pour animaux à base de matières d’origine fongique, p. ex. de champignons à base de matières résiduelles
A23K 20/20 - Substances inorganiques, p. ex. oligo-éléments
A23K 20/105 - Composés aliphatiques ou alicycliques
KYOTO PREFECTURAL PUBLIC UNIVERSITY CORPORATION (Japon)
SHINSHU UNIVERSITY (Japon)
Inventeur(s)
Kishimoto, Megumi
Shimizu, Yuto
Sato, Yushi
Takeda, Shigenori
Yagyu, Shigeki
Nakazawa, Yozo
Tanaka, Miyuki
Abrégé
The present invention relates to a method for culturing T cells, the method comprising a step for bringing a composition containing T cells into contact with a stimulant, wherein the stimulant activates (i) one or more intracellular signaling domains of one or more components of a TCR complex and (ii) one or more intracellular signaling domains of one or more co-stimulatory molecules. This method makes it possible to maintain and proliferate T cells in a composition containing the T cells into a cell group suitable for gene transfer.
C07K 16/28 - Immunoglobulines, p. ex. anticorps monoclonaux ou polyclonaux contre du matériel provenant d'animaux ou d'humains contre des récepteurs, des antigènes de surface cellulaire ou des déterminants de surface cellulaire
A free-range livestock management server apparatus acquires information related to an individual animal or a location; identifies the individual animal based on acquired information; identifies location based on acquired information; grasps condition of individual animal or the location based on acquired information; monitors an abnormal condition of the individual animal or the location based on acquired information; sorts the information related to identified individual animal, identified location, grasped condition, and monitored abnormal condition for the identified individual animal or the identified location to associate each piece of the information with the identified individual animal or the identified location; stores the sorted and associated information; determines urgency of information related to abnormal condition of the individual animal or the location among the stored information based on a preset criterion; and creates notification information based on the information determined urgent to transmit the notification information to a predetermined terminal(s).
G06V 10/77 - Traitement des caractéristiques d’images ou de vidéos dans les espaces de caractéristiquesDispositions pour la reconnaissance ou la compréhension d’images ou de vidéos utilisant la reconnaissance de formes ou l’apprentissage automatique utilisant l’intégration et la réduction de données, p. ex. analyse en composantes principales [PCA] ou analyse en composantes indépendantes [ ICA] ou cartes auto-organisatrices [SOM]Séparation aveugle de source
G06V 40/10 - Corps d’êtres humains ou d’animaux, p. ex. occupants de véhicules automobiles ou piétonsParties du corps, p. ex. mains
12.
Negative Electrode Active Material for Secondary Battery, Manufacturing Method Thereof, Negative Electrode for Secondary Battery and Secondary Battery
A negative electrode active material for a secondary battery (102) of the present invention contains an active material particle (106) which contains a silicon composite (103) and a self-assembled monolayer 104 that covers a surface of the silicon composite (103) and has an amino group and a binder (105) bonded to the self-assembled monolayer 104 through the amino group, and the binder (105) contains a first carbon nanotube having a length of 1000 nm or less and a second carbon nanotube having a length of 2 μm or more.
A method for producing Y2Ti2O5S2, including: placing sulfur, Y2O3, TiO2, Y2S3, and at least one flux selected from a halide of an alkali metal in a lower portion of a reaction vessel having an opening at an upper end; then vaporizing the sulfur and allowing the vaporized sulfur to react with Y2O3, TiO2, and Y2S3 to obtain Y2Ti2O5S2 by heating the lower portion of the reaction vessel in a state where the opening of the reaction vessel is held upward and closed while an upper portion of the reaction vessel is not heated; and liquefying the vaporized sulfur in the upper portion of the reaction vessel to allow the liquefied sulfur to fall down and again vaporizing the liquefied sulfur in the heated lower portion of the reaction vessel, in which liquefaction and vaporization are repeatedly carried out, and allowing the vaporized sulfur to react with Y2O3, TiO2, and Y2S3.
Provided is a silk fibroin tubular substance used for reproducing a biological tissue. The silk fibroin tubular substance exhibits a porous makeup at room temperature, the patency rate of the silk fibroin tubular substance when a 1N load is applied thereon in a water-saturated state being 10%-50%.
C07K 14/435 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'animauxPeptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'humains
15.
POSITIVE-ELECTRODE ACTIVE MATERIAL FOR LITHIUM-ION SECONDARY BATTERY, POSITIVE ELECTRODE, LITHIUM-ION SECONDARY BATTERY, AND METHOD FOR MANUFACTURING POSITIVE-ELECTRODE ACTIVE MATERIAL FOR LITHIUM-ION SECONDARY BATTERY
Provided is a positive-electrode active material for a lithium-ion secondary battery able to achieve an even higher capacity, improved cycle characteristics and discharge characteristics, and a low cost.
Provided is a positive-electrode active material for a lithium-ion secondary battery able to achieve an even higher capacity, improved cycle characteristics and discharge characteristics, and a low cost.
The positive-electrode active material 11 for a lithium-ion secondary battery has a fluoride layer 11b which coats at least part of a core particle 11a and is formed of fluoride of the lithium metal composite oxide. The lithium metal composite oxide of the core particle 11a is represented by LiNikColMnmO2 (k+1+m=1, k≥0.6). In addition, the fluoride of the lithium metal composite oxide of the fluoride layer 11b is represented by Li1-zNikColMnmO2-xFx (k+1+m=1, k≥0.6, z≤0.62, 0
H01M 4/1315 - Électrodes à base d'oxydes ou d'hydroxydes mixtes, ou de mélanges d'oxydes ou d'hydroxydes, p. ex. LiCoOx contenant des atomes d'halogène, p. ex. LiCoOxFy
H01M 4/505 - Emploi de substances spécifiées comme matériaux actifs, masses actives, liquides actifs d'oxydes ou d'hydroxydes inorganiques de manganèse d'oxydes ou d'hydroxydes mixtes contenant du manganèse pour insérer ou intercaler des métaux légers, p. ex. LiMn2O4 ou LiMn2OxFy
H01M 4/525 - Emploi de substances spécifiées comme matériaux actifs, masses actives, liquides actifs d'oxydes ou d'hydroxydes inorganiques de nickel, de cobalt ou de fer d'oxydes ou d'hydroxydes mixtes contenant du fer, du cobalt ou du nickel pour insérer ou intercaler des métaux légers, p. ex. LiNiO2, LiCoO2 ou LiCoOxFy
H01M 4/58 - Emploi de substances spécifiées comme matériaux actifs, masses actives, liquides actifs de composés inorganiques autres que les oxydes ou les hydroxydes, p. ex. sulfures, séléniures, tellurures, halogénures ou LiCoFyEmploi de substances spécifiées comme matériaux actifs, masses actives, liquides actifs de structures polyanioniques, p. ex. phosphates, silicates ou borates
H01M 10/0525 - Batteries du type "rocking chair" ou "fauteuil à bascule", p. ex. batteries à insertion ou intercalation de lithium dans les deux électrodesBatteries à l'ion lithium
Problem: To provide a cell culture substrate, a cell culture vessel, and a cell detachment method for adherent cells, which enable easier detachment of adherent cells compared to a case where trypsin is used. Solution: A cell culture substrate for coating a cell culture vessel, the substrate containing, as an active ingredient, one or more proteins of a silk protein, a silk protein hydrolysate, fibroin, and a fibroin hydrolysate.
C12M 1/12 - Appareillage pour l'enzymologie ou la microbiologie avec des moyens de stérilisation, filtration ou dialyse
C12M 1/00 - Appareillage pour l'enzymologie ou la microbiologie
17.
SINGLE CRYSTALLINE TA3N5 NANOPARTICLES MODIFIED WITH A MOX COCATALYST, A CATALYST, METHODS FOR WATER SPLITTING USING THE CATALYST, AND METHODS TO MAKE SAME
Tantalum nitride and specifically a novel Ta3N5 nanoparticles, such as single crystalline Ta3N5 nanoparticles, are disclosed. The nanoparticles used with a co-catalyst is further disclosed. The present invention also relates to Ta3N5 nanoparticles modified with a metal oxide, such as a CoOxcocatalyst, wherein Ox represents an oxide that is part of the cobalt oxide. A catalyst, such as for water oxidation to produce O2, is disclosed. The nanoparticles can further be modified to include a water reducing catalyst. A water splitting catalyst is further disclosed. Methods of making the nanoparticles and catalyst are also disclosed. Methods to split water utilizing the catalyst are further described.
Provided is a coating agent that is able to yield a novel coating film. The present invention relates to a coating agent that contains a compound which has, in the molecule, a betaine structure and a structure represented by formula (1). (R1is an organic group or a group having an Si-O bond, R2is an organic group or a group having an Si-O bond, R1and R2may be the same as, or different from, each other, n is an integer of 2 or higher, multiple R1moieties may be the same as, or different from, each other, and multiple R2 moieties may be the same as, or different from, each other.)
C09D 133/14 - Homopolymères ou copolymères d'esters d'esters contenant des atomes d'halogène, d'azote, de soufre ou d'oxygène en plus de l'oxygène du radical carboxyle
NATIONAL UNIVERSITY CORPORATION TOKAI NATIONAL HIGHER EDUCATION AND RESEARCH SYSTEM (Japon)
SHINSHU UNIVERSITY (Japon)
Inventeur(s)
Ueno Yoshihito
Hiratsuka Sachie
Tomita Takeshi
Abrégé
Provided are an agent containing RNA as an active ingredient and capable of strongly activating cells, and uses thereof. An RNA containing a base sequence represented by SEQ ID NO: 1 or a base sequence having 90% or more identity with the sequence has a cell activating ability.
A61K 31/7088 - Composés ayant au moins trois nucléosides ou nucléotides
A61K 31/712 - Acides nucléiques ou oligonucléotides ayant des sucres modifiés, c.-à-d. autres que le ribose ou le 2'-désoxyribose
A61K 31/7115 - Acides nucléiques ou oligonucléotides ayant des bases modifiées, c.-à-d. autres que l'adénine, la guanine, la cytosine, l'uracile ou la thymine
[Solution] Provided is a gel composition which contains a vinyl chloride-based resin and a plasticizer and which exhibits a gel state at 20°C. The plasticizer is at least one selected from the group consisting of isophthalic acid esters, terephthalic acid esters, fumaric acid esters, acetylricinoleic acid esters, citric acid esters, acetylcitric acid esters, adipic acid esters selected from di-2-ethylhexyl adipate (DOA) and diisononyl adipate (DINA), maleic acid esters and derivatives thereof and salts thereof. Also provided is an electronic element comprising a first electrode, a second electrode, and a polymer layer which is disposed between the first electrode and the second electrode and which contains the gel composition.
COMPOSITION AND METHOD FOR INCREASING INTESTINAL BUTYRIC ACID, COMPOSITION AND METHOD FOR INCREASING MUSCLE MASS, COMPOSITION AND METHOD FOR PREVENTING OR AMELIORATING OBESITY, COMPOSITION AND METHOD FOR INCREASING NUMBER OF BACTERIA OF GENUS ALISTIPES, COMPOSITION AND METHOD FOR REDUCING NUMBER OF BACTERIA OF GENUS ROMBOUTSIA, AND USE OF SILKWORM POWDER FOR PRODUCTION OF THESE COMPOSITIONS
[Problem] To provide a novel use of silkworm on the basis on novel knowledge relating to the functionality of the silkworm. According to the present invention, butyric acid can be increased in the intestine. As a result, known useful effects of butyric acid (e.g., prevention and amelioration of obesity, muscle atrophy, intestinal inflammations, rheumatoid arthritis, graft versus host diseases, fatty liver, colorectal cancer, etc.) can be expected. Further, according to the present invention, muscle mass can be increased. As a result, effects such as the prevention of sarcopenia and muscle atrophy, the enhancement of physical strength, the improvement of activity and the like can be expected. [Solution] A composition for increasing intestinal butyric acid, the composition containing a silkworm powder as an active ingredient.
A61K 35/64 - Insectes, p. ex. abeilles, guêpes ou puces
A23L 33/10 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs
A61P 1/00 - Médicaments pour le traitement des troubles du tractus alimentaire ou de l'appareil digestif
A61P 1/16 - Médicaments pour le traitement des troubles du tractus alimentaire ou de l'appareil digestif des troubles de la vésicule biliaire ou du foie, p. ex. protecteurs hépatiques, cholagogues, cholélitholytiques
A61P 9/00 - Médicaments pour le traitement des troubles du système cardiovasculaire
A61P 9/10 - Médicaments pour le traitement des troubles du système cardiovasculaire des maladies ischémiques ou athéroscléreuses, p. ex. médicaments antiangineux, vasodilatateurs coronariens, médicaments pour le traitement de l'infarctus du myocarde, de la rétinopathie, de l'insuffisance cérébro-vasculaire, de l'artériosclérose rénale
A61P 21/00 - Médicaments pour le traitement des troubles du système musculaire ou neuromusculaire
A61P 25/00 - Médicaments pour le traitement des troubles du système nerveux
A61P 29/00 - Agents analgésiques, antipyrétiques ou anti-inflammatoires non centraux, p. ex. agents antirhumatismauxMédicaments anti-inflammatoires non stéroïdiens [AINS]
A light condensing unit 1 according to the present invention comprises: a spherical lens 10 that receives a light beam 60; and a first ellipsoid 22a that guides the light beam emitted from the spherical lens 10. The first ellipsoid 22a is formed from a material the refractive index of which increases by light irradiation, and the spherical lens 10 and the first ellipsoid 22a are disposed such that the center C of the spherical lens 10 and a first focus f1 of the first ellipsoid 22a match. According to this light condensing unit 1, sunlight can be condensed with high light condensing efficiency.
F24S 20/30 - Collecteurs de chaleur solaire pour chauffer des objets, p. ex. fours solaires ou fourneaux solaires
F24S 23/30 - Agencements pour concentrer les rayons solaires pour les collecteurs de chaleur solaire avec des lentilles
G02B 6/32 - Moyens de couplage optique ayant des moyens de focalisation par lentilles
G02B 13/00 - Objectifs optiques spécialement conçus pour les emplois spécifiés ci-dessous
G02B 13/18 - Objectifs optiques spécialement conçus pour les emplois spécifiés ci-dessous avec des lentilles ayant une ou plusieurs surfaces non sphériques, p. ex. pour réduire l'aberration géométrique
H02S 40/22 - Moyens réflecteurs ou concentrateurs de lumière
23.
PHARMACEUTICAL COMPOSITION FOR PREVENTING AND/OR TREATING HEART FAILURE
An object of the present invention is to provide a pharmaceutical composition for preventing and/or treating heart failure. The invention relates to a pharmaceutical composition for preventing and/or treating heart failure, comprising a compound represented by formula (1), a salt thereof, or a prodrug thereof:
An object of the present invention is to provide a pharmaceutical composition for preventing and/or treating heart failure. The invention relates to a pharmaceutical composition for preventing and/or treating heart failure, comprising a compound represented by formula (1), a salt thereof, or a prodrug thereof:
wherein
A is an optionally substituted benzene ring;
B is an optionally substituted aryl or an optionally substituted heteroaryl;
X is an oxygen atom or a sulfur atom;
Y is a nitrogen atom or a carbon atom;
of Y is a single or double bond when Y is a carbon atom, or
of Y is a single bond when Y is a nitrogen atom;
each R1 independently represents lower alkyl, or
two R1s may be bound to each other to form a spiro ring or a crosslinked structure, or
two R1s may be bound to each other to form a saturated fused heterocycle together with nitrogen and carbon atoms constituting a ring containing Y;
p is 0, 1, or 2; or
(R1)p is oxo.
A61K 31/496 - Pipérazines non condensées contenant d'autres hétérocycles, p. ex. rifampine, thiothixène ou sparfloxacine
A61K 31/4439 - Pyridines non condenséesLeurs dérivés hydrogénés contenant d'autres systèmes hétérocycliques contenant un cycle à cinq chaînons avec l'azote comme hétéro-atome du cycle, p. ex. oméprazole
A61K 31/444 - Pyridines non condenséesLeurs dérivés hydrogénés contenant d'autres systèmes hétérocycliques contenant un cycle à six chaînons avec l'azote comme hétéro-atome du cycle, p. ex. amrinone
A61K 31/4995 - Pyrazines ou pipérazines formant une partie de systèmes cycliques pontés
A61P 9/04 - Agents inotropes, c.-à-d. stimulants de la contraction cardiaqueMédicaments pour le traitement de l'insuffisance cardiaque
This CASK disorder treating agent contains, as an active ingredient, at least one kinase inhibitor selected from the group consisting of JNK inhibitors and p38 MAPK inhibitors.
Problem: To provide a cell culture substrate, a cell culture container, a kit, a method for detaching adherent cells, a method for culturing adherent cells, a cell recovery device, and a cell culture system, with each of which adherent cells can be detached more easily compared with the cases where trypsin is used and the adherent cells can be cultured more efficiently. Solution: A substrate for coating a cell culture container to be used for culturing adherent cells, the substrate comprising a first scaffold component being one or more proteins and a second scaffold component having a composition different from that of the first scaffold component, the second scaffold component being one or more proteins contained in an extracellular matrix.
C12N 5/00 - Cellules non différenciées humaines, animales ou végétales, p. ex. lignées cellulairesTissusLeur culture ou conservationMilieux de culture à cet effet
C12M 1/00 - Appareillage pour l'enzymologie ou la microbiologie
C12M 3/00 - Appareillage pour la culture de tissus, de cellules humaines, animales ou végétales, ou de virus
C12N 1/00 - Micro-organismes, p. ex. protozoairesCompositions les contenantProcédés de culture ou de conservation de micro-organismes, ou de compositions les contenantProcédés de préparation ou d'isolement d'une composition contenant un micro-organismeLeurs milieux de culture
C12N 1/02 - Séparation des micro-organismes de leurs milieux de culture
26.
WHITE MYCELIUM BLOCK, WHITE MYCELIUM PULP AND MOLDED BODY THEREOF, MICRONIZED WHITE MYCELIUM PULP AND MOLDED BODY THEREOF, AND METHODS FOR PRODUCING SAME
A white material in which binding between mycelium cells is relaxed while leaving a structure peculiar to a subject mushroom without defibration, and a white material in which the fiber form of the mycelium is maintained while an original solid form is decomposed by defibration and a molded body thereof are obtained. Further addressed is the problem of obtaining a white material in which mycelia fibers are further refined by further defibrating the white material in which the fiber form of mycelia is maintained, and a molded body thereof. As the solution, a process for producing a white mycelium block comprises repeating once or a plurality of times a series of bleaching/relaxation treatments comprising bringing a fruit body of a mushroom into contact with an alkaline aqueous solution (S101), bringing the fruit body into contact with hydrogen peroxide water (S103), and then irradiating the fruit body with light including ultraviolet rays having a wavelength of at least 380 nm or less (S104), to thereby relax the binding between mycelium cells constituting the fruit body and bleach the fruit body. The process for producing a white mycelium pulp comprises further physically defibrating the white mycelium block (S206). A process for producing a micronized white mycelium pulp comprises further physically defibrating the white mycelium pulp (S207).
D21B 1/02 - Traitement préalable des matières premières par des moyens chimiques ou physiques
A23L 19/00 - Produits à base de fruits ou de légumesLeur préparation ou leur traitement
D06M 10/00 - Traitement physique des fibres, fils, filés, tissus ou articles fibreux faits de ces matières, p. ex. ultrasonique, effet corona, irradiation, courants électriques ou champs magnétiquesTraitement physique combiné avec le traitement avec des composés ou des éléments chimiques
D06M 11/00 - Traitement des fibres, fils, filés, tissus ou des articles fibreux faits de ces matières, avec des substances inorganiques ou leurs complexesUn tel traitement combiné avec un traitement mécanique, p. ex. mercerisage
D21C 1/06 - Traitement préalable des matériaux finement divisés avant la cuisson avec des composés à réaction alcaline
27.
YARN RAW MATERIAL, YARN, FIBER PRODUCT, AND METHOD FOR PRODUCING YARN
The purpose of the present invention is to provide a useful yarn raw material that can be produced even from fibers or the like that are usually difficult to recycle, such as cut pile fibers. The present invention provides a yarn raw material comprising: a fiber having a plurality of hydroxyl groups on the surface thereof; and a polymer that is disposed on the surface of the fiber and has a plurality of carboxy groups and/or phosphate groups, wherein at least a portion of the plurality of hydroxyl groups and a portion of the carboxy groups and/or the phosphate groups form an ester bond and/or a phosphate ester bond.
D06M 15/263 - Composés macromoléculaires obtenus par des réactions faisant intervenir uniquement des liaisons non saturées carbone-carbone d'acides carboxyliques non saturésLeurs sels ou esters
By subjecting a two-layer structure containing a substrate and a thin film formed on the substrate to irradiation with a short pulse laser using interference machining, the method for manufacturing a processed product forms a relief structure having a prescribed period on the surface of the substrate and forms particles that are scattered on the relief structure.
B23K 26/354 - Travail par rayon laser, p. ex. soudage, découpage ou perçage pour le traitement de surface par fusion
B23K 26/402 - Enlèvement de matière en tenant compte des propriétés du matériau à enlever en faisant intervenir des matériaux non métalliques, p. ex. des isolants
B29C 59/16 - Façonnage de surface, p. ex. gaufrageAppareils à cet effet par énergie ondulatoire ou rayonnement corpusculaire
29.
IMAGE PROCESSING DEVICE, IMAGE PROCESSING METHOD, AND PROGRAM
Provided is an image processing device, an image processing method, or a program that can obtain an image for lens opacity determination that facilitates opacity determination for a lens. An image processing device acquires a transillumination image of a lens captured by a capturing device, and performs a flat correction process to reduce illumination unevenness in the transillumination image. In the flat correction process, an average filter is generated on the basis of an original image of the transillumination image, the original image is divided by the average filter, and values after division are multiplied by an average luminance of the original image. The transillumination image after the flat correction process is converted to a binarized image composed of white and black. Determination for lens opacity is performed on the basis of the binarized image.
A system includes: one or more memories; and one or more processors configured to, acquire three-dimensional data of an environment at a first timing; extract a plurality of pieces of motion data from the one or more memories, the motion data including the target end-effector position and attitude and a swept volume that does not contact the environment; start the task based on first motion data, the first motion data being one of the extracted pieces of motion data; when determination is made that the mobile manipulator comes into contact with the environment, extract, as second motion data, motion data including a swept volume that does not contact the environment based on the three-dimensional data acquired in real time; and generate a transition trajectory for transitioning from a trajectory of the first motion data to a trajectory of the second motion data.
G05B 19/4155 - Commande numérique [CN], c.-à-d. machines fonctionnant automatiquement, en particulier machines-outils, p. ex. dans un milieu de fabrication industriel, afin d'effectuer un positionnement, un mouvement ou des actions coordonnées au moyen de données d'un programme sous forme numérique caractérisée par le déroulement du programme, c.-à-d. le déroulement d'un programme de pièce ou le déroulement d'une fonction machine, p. ex. choix d'un programme
This composition for attracting terrestrial mollusks contains at least one selected from the group consisting of fatty acids having 14-30 carbons in the fatty acid portion, fatty acid esters having 14-30 carbons in the fatty acid portion, and fatty acid amides having 14-30 carbons in the fatty acid portion.
An electrode material 1 for secondary batteries that suppresses reductions in electrode capacity and has excellent cycle characteristics includes an electrode active material 10. All or a portion of the surface of the electrode active material 10 is coated with a non-aqueous binder 20 in a shell-like manner.
H01M 4/58 - Emploi de substances spécifiées comme matériaux actifs, masses actives, liquides actifs de composés inorganiques autres que les oxydes ou les hydroxydes, p. ex. sulfures, séléniures, tellurures, halogénures ou LiCoFyEmploi de substances spécifiées comme matériaux actifs, masses actives, liquides actifs de structures polyanioniques, p. ex. phosphates, silicates ou borates
H01M 4/13 - Électrodes pour accumulateurs à électrolyte non aqueux, p. ex. pour accumulateurs au lithiumLeurs procédés de fabrication
H01M 4/36 - Emploi de substances spécifiées comme matériaux actifs, masses actives, liquides actifs
H01M 4/485 - Emploi de substances spécifiées comme matériaux actifs, masses actives, liquides actifs d'oxydes ou d'hydroxydes inorganiques d'oxydes ou d'hydroxydes mixtes pour insérer ou intercaler des métaux légers, p. ex. LiTi2O4 ou LiTi2OxFy
H01M 4/505 - Emploi de substances spécifiées comme matériaux actifs, masses actives, liquides actifs d'oxydes ou d'hydroxydes inorganiques de manganèse d'oxydes ou d'hydroxydes mixtes contenant du manganèse pour insérer ou intercaler des métaux légers, p. ex. LiMn2O4 ou LiMn2OxFy
H01M 4/525 - Emploi de substances spécifiées comme matériaux actifs, masses actives, liquides actifs d'oxydes ou d'hydroxydes inorganiques de nickel, de cobalt ou de fer d'oxydes ou d'hydroxydes mixtes contenant du fer, du cobalt ou du nickel pour insérer ou intercaler des métaux légers, p. ex. LiNiO2, LiCoO2 ou LiCoOxFy
H01M 4/62 - Emploi de substances spécifiées inactives comme ingrédients pour les masses actives, p. ex. liants, charges
33.
PHOTOCATALYST PRODUCTION METHOD, AND HYDROGEN AND OXYGEN PRODUCTION METHOD USING SAID PHOTOCATALYST
JAPAN TECHNOLOGICAL RESEARCH ASSOCIATION OF ARTIFICIAL PHOTOSYNTHETIC CHEMICAL PROCESS (Japon)
Inventeur(s)
Yoshida, Hiroaki
Tsutsuminai, Susumu
Kariya, Nobuko
Domen, Kazunari
Hisatomi, Takashi
Lin, Lihua
Tao, Xiaoping
Liang, Xizhuang
Abrégé
Provided is a photocatalyst with significantly enhanced water splitting performance in YTOS or in a composition in which the yttrium element of YTOS has been replaced with another element. Also provided is a method for producing a photocatalyst that has a composition represented by the following general formula (I), the method including mixing, with a raw material of the photocatalyst, a flux component at a mass ratio of 0.01 times to 50 times, the flux component being composed of one or more chlorides and/or iodides of at least one selected from Li, Na, K, Rb, Mg, Ca, Sr, and Ba, and calcining a resultant product at 450° C. to 1050° C.:
Provided is a photocatalyst with significantly enhanced water splitting performance in YTOS or in a composition in which the yttrium element of YTOS has been replaced with another element. Also provided is a method for producing a photocatalyst that has a composition represented by the following general formula (I), the method including mixing, with a raw material of the photocatalyst, a flux component at a mass ratio of 0.01 times to 50 times, the flux component being composed of one or more chlorides and/or iodides of at least one selected from Li, Na, K, Rb, Mg, Ca, Sr, and Ba, and calcining a resultant product at 450° C. to 1050° C.:
MaTibOcSd (I)
Provided is a photocatalyst with significantly enhanced water splitting performance in YTOS or in a composition in which the yttrium element of YTOS has been replaced with another element. Also provided is a method for producing a photocatalyst that has a composition represented by the following general formula (I), the method including mixing, with a raw material of the photocatalyst, a flux component at a mass ratio of 0.01 times to 50 times, the flux component being composed of one or more chlorides and/or iodides of at least one selected from Li, Na, K, Rb, Mg, Ca, Sr, and Ba, and calcining a resultant product at 450° C. to 1050° C.:
MaTibOcSd (I)
(where M is a combination of one or more selected from Pr, Nd, Pm, Sm, Eu, Gd, Tb, Dy, Ho, Er, Tm, and Y, a is a number of 1.7 to 2.3, b is a number of 2, c is a number of 4.7 to 5.3, and d is a number of 1.7 to 2.3).
B01J 19/12 - Procédés utilisant l'application directe de l'énergie ondulatoire ou électrique, ou un rayonnement particulaireAppareils à cet usage utilisant des radiations électromagnétiques
C25B 1/04 - Hydrogène ou oxygène par électrolyse de l'eau
Disclosed is a pharmaceutical composition for treating facioscapulohumeral dystrophy, the pharmaceutical composition containing a compound represented by formula (1) or a salt thereof as an active ingredient. (In formula (1), X represents H, a C1-C6 alkyl group, a C2-C6 alkenyl group, or a C2-C6 alkynyl group; and R1, R2, R3and R4 each independently represent H, a C1-C6 alkyl group, a C2-C6 alkenyl group, or a C2-C6 alkynyl group.)
A61K 31/427 - Thiazoles non condensés et contenant d'autres hétérocycles
A61P 21/00 - Médicaments pour le traitement des troubles du système musculaire ou neuromusculaire
A61P 29/00 - Agents analgésiques, antipyrétiques ou anti-inflammatoires non centraux, p. ex. agents antirhumatismauxMédicaments anti-inflammatoires non stéroïdiens [AINS]
C07D 277/46 - Radicaux amino ou imino acylés par les acides carboxyliques ou par leurs analogues du soufre ou de l'azote
35.
POSITIVE ELECTRODE MATERIAL, METHOD FOR MANUFACTURING POSITIVE ELECTRODE MATERIAL, AND SECONDARY BATTERY
A positive electrode material for secondary batteries that has exceptional high rate characteristics and cycle characteristics, the positive electrode material containing a positive electrode active material 10 and a crystalline metal oxide 20 that is attached to part of the surface of the positive electrode active material 10.
H01M 4/36 - Emploi de substances spécifiées comme matériaux actifs, masses actives, liquides actifs
H01M 4/505 - Emploi de substances spécifiées comme matériaux actifs, masses actives, liquides actifs d'oxydes ou d'hydroxydes inorganiques de manganèse d'oxydes ou d'hydroxydes mixtes contenant du manganèse pour insérer ou intercaler des métaux légers, p. ex. LiMn2O4 ou LiMn2OxFy
H01M 4/525 - Emploi de substances spécifiées comme matériaux actifs, masses actives, liquides actifs d'oxydes ou d'hydroxydes inorganiques de nickel, de cobalt ou de fer d'oxydes ou d'hydroxydes mixtes contenant du fer, du cobalt ou du nickel pour insérer ou intercaler des métaux légers, p. ex. LiNiO2, LiCoO2 ou LiCoOxFy
H01M 4/58 - Emploi de substances spécifiées comme matériaux actifs, masses actives, liquides actifs de composés inorganiques autres que les oxydes ou les hydroxydes, p. ex. sulfures, séléniures, tellurures, halogénures ou LiCoFyEmploi de substances spécifiées comme matériaux actifs, masses actives, liquides actifs de structures polyanioniques, p. ex. phosphates, silicates ou borates
An insulating resin comprising (A) a thermoplastic resin which is at least one resin selected from among polycarbonate resins, polyester resins, and polyarylate resins and (B) a metal diketone complex crosslinked by an ether bond and containing at least one β-diketone as a ligand.
C08L 101/12 - Compositions contenant des composés macromoléculaires non spécifiés caractérisées par des propriétés physiques, p. ex. anisotropie, viscosité ou conductivité électrique
C08L 67/00 - Compositions contenant des polyesters obtenus par des réactions créant une liaison ester carboxylique dans la chaîne principaleCompositions contenant des dérivés de tels polymères
C08L 69/00 - Compositions contenant des polycarbonatesCompositions contenant des dérivés des polycarbonates
H01B 3/42 - Isolateurs ou corps isolants caractérisés par le matériau isolantEmploi de matériaux spécifiés pour leurs propriétés isolantes ou diélectriques composés principalement de substances organiques matières plastiquesIsolateurs ou corps isolants caractérisés par le matériau isolantEmploi de matériaux spécifiés pour leurs propriétés isolantes ou diélectriques composés principalement de substances organiques résinesIsolateurs ou corps isolants caractérisés par le matériau isolantEmploi de matériaux spécifiés pour leurs propriétés isolantes ou diélectriques composés principalement de substances organiques cires polyestersIsolateurs ou corps isolants caractérisés par le matériau isolantEmploi de matériaux spécifiés pour leurs propriétés isolantes ou diélectriques composés principalement de substances organiques matières plastiquesIsolateurs ou corps isolants caractérisés par le matériau isolantEmploi de matériaux spécifiés pour leurs propriétés isolantes ou diélectriques composés principalement de substances organiques résinesIsolateurs ou corps isolants caractérisés par le matériau isolantEmploi de matériaux spécifiés pour leurs propriétés isolantes ou diélectriques composés principalement de substances organiques cires polyéthersIsolateurs ou corps isolants caractérisés par le matériau isolantEmploi de matériaux spécifiés pour leurs propriétés isolantes ou diélectriques composés principalement de substances organiques matières plastiquesIsolateurs ou corps isolants caractérisés par le matériau isolantEmploi de matériaux spécifiés pour leurs propriétés isolantes ou diélectriques composés principalement de substances organiques résinesIsolateurs ou corps isolants caractérisés par le matériau isolantEmploi de matériaux spécifiés pour leurs propriétés isolantes ou diélectriques composés principalement de substances organiques cires polyacétals
KYOTO PREFECTURAL PUBLIC UNIVERSITY CORPORATION (Japon)
SHINSHU UNIVERSITY (Japon)
Inventeur(s)
Kishimoto, Megumi
Shimizu, Yuto
Kubota, Susumu
Yagyu, Shigeki
Suematsu, Masaya
Nakazawa, Yozo
Tanaka, Miyuki
Abrégé
The present invention provides a method for producing a chimeric antigen receptor T (CAR-T) cell, including a step of bead separating with a specific factor a T cell from a T cell source, wherein the specific factor is CD45RA+ or the like. The method enables production of CAR-T cells high antitumor property, and can produce highly functional CAR-T cells conveniently in a short time at a low cost.
This hydrazine-containing waste water treatment method includes a photocatalyst treatment step for performing oxidative decomposition of hydrazine in hydrazine-containing waste water with a photocatalyst. The hydrazine-containing waste water treatment facility 1 is provided with: a reaction tank 20 in which hydrazine-containing waste water 10 is stored; and a photocatalyst 30 which is provided in the reaction tank 20.
C02F 1/72 - Traitement de l'eau, des eaux résiduaires ou des eaux d'égout par oxydation
B01J 23/02 - Catalyseurs contenant des métaux, oxydes ou hydroxydes métalliques non prévus dans le groupe des métaux alcalins ou alcalino-terreux ou du béryllium
A determination device 1 includes: an acquisition unit 21 that acquires digital color image data 11 of a region of interest in melanonychia of a subject; a calculation unit 23 that calculates an indicator value 12 from variation in RGB values of each pixel of the digital color image data 11; and an output unit 24 that outputs a result of determining that the melanonychia is malignant if the indicator value 12 is higher than a threshold value and determining that the melanonychia is benign if the indicator value 12 is lower than the threshold value.
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
A61B 5/103 - Dispositifs de mesure pour le contrôle de la forme, du dessin, de la dimension ou du mouvement du corps ou de parties de celui-ci, à des fins de diagnostic
In a carbon molecular sieve of the present invention, the half-value width of a main peak of an oxygen adsorption rate constant distribution is less than or equal to 0.35 s-122 at 25℃ according to the BET method is 300 m2/g to 600 m2/g, inclusive.
B01J 20/20 - Compositions absorbantes ou adsorbantes solides ou compositions facilitant la filtrationAbsorbants ou adsorbants pour la chromatographieProcédés pour leur préparation, régénération ou réactivation contenant une substance inorganique contenant du carbone libreCompositions absorbantes ou adsorbantes solides ou compositions facilitant la filtrationAbsorbants ou adsorbants pour la chromatographieProcédés pour leur préparation, régénération ou réactivation contenant une substance inorganique contenant du carbone obtenu par des procédés de carbonisation
B01J 20/28 - Compositions absorbantes ou adsorbantes solides ou compositions facilitant la filtrationAbsorbants ou adsorbants pour la chromatographieProcédés pour leur préparation, régénération ou réactivation caractérisées par leur forme ou leurs propriétés physiques
B01J 20/30 - Procédés de préparation, de régénération ou de réactivation
C01B 37/00 - Composés ayant des propriétés de tamis moléculaires mais n'ayant pas de propriétés d'échangeurs de base
41.
INFORMATION PROCESSING SYSTEM, INFORMATION PROCESSING METHOD, AND PROGRAM
[Problem] To make it possible to provide food information optimal for an individual user. [Solution] The present invention is characterized by comprising: a prediction model storage unit that stores a prediction model which predicts, for each user, body data relating to the body of the user on the basis of intake amounts of a plurality of food components taken by the user and which includes, for each of the food components, the degree by which the food component improves or deteriorates the body data; a food database that stores the amounts of food components contained in food; and an influence amount calculation unit that calculates an influence amount which is the amount by which the food improves or deteriorates the body data of the user on the basis of the amounts of the food components contained in the food and the degree relating to the food components.
G16H 20/60 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant le contrôle de l’alimentation, p. ex. les régimes
A rubber composition comprising a nanocellulose and a rubber component, wherein the nanocellulose contains a cellulose raw material oxide derived from hypochlorous acid or a salt thereof and does not substantially contain an N-oxyl compound. The ratio of the value of elongation at break of a rubber formed from said rubber composition to the value of elongation at break of a rubber formed from a control rubber composition in which the nanocellulose has been removed from said rubber composition is at least 0.90 and less than 1.15.
Single crystalline nanoparticles that are tantalum nitride doped with at least one metal are described. The single crystalline nanoparticles can be doped with two metals such as Zr and Mg. The single crystalline nanoparticles can be Ta3N5:Mg+Zr, or Ta3N5:Mg, or Ta3N5:Zr or any combination thereof. Catalyst containing the single crystalline nanoparticles alone or with one or more co-catalyst are further described along with methods of making the nanoparticles and catalyst. Methods to split water utilizing the catalyst are further described.
B01J 35/23 - Catalyseurs caractérisés par leur forme ou leurs propriétés physiques, en général caractérisés par leur état non solide sous forme colloïdale
The carbon nanotube structure in which a plurality of carbon nanotubes are assembled includes a joining portion of end portions of carbon nanotubes and a joining portion of an end portion and a side wall portion of the carbon nanotubes.
This diagnosis method comprises: a marker complex concentration measurement step for disposing, on a substrate, a photoacid and an anti-marker antibody that specifically binds with a marker and providing a test sample thereon to measure the concentration of a marker complex in which the anti-marker antibody and a marker in the test sample are bound; and a marker dissociation step for irradiating the photoacid with light to dissociate the marker from the marker complex.
G01N 33/543 - Tests immunologiquesTests faisant intervenir la formation de liaisons biospécifiquesMatériaux à cet effet avec un support insoluble pour l'immobilisation de composés immunochimiques
Disclosed is a magnetic sensor head which comprises an optical fiber, a GI fiber having one end that is optically connected to the optical fiber, a magnetic film that is bonded to the other end of the GI fiber, and a reflective film that is bonded to a surface of the magnetic film, the surface being on the reverse side of the surface that is bonded to the GI fiber. The magnetic film is formed of a rare earth iron garnet thin film; and the slope of the sum of squared differences of the rare earth iron garnet thin film with respect to the applied magnetic field is 100 or more.
G01R 33/032 - Mesure de la direction ou de l'intensité de champs magnétiques ou de flux magnétiques en utilisant des dispositifs magnéto-optiques, p. ex. par effet Faraday
47.
Semipermeable composite membrane, method of producing same, and semipermeable composite membrane element
The invention provides a semipermeable composite membrane that reduces an environmental load, and a method of producing the semipermeable composite membrane. A semipermeable composite membrane 100 includes, on a porous support 102, a semipermeable membrane 104 containing a crosslinked polyamide 120 and a cellulose nanofiber 110. A method of producing the semipermeable composite membrane includes obtaining a mixed solution containing the cellulose nanofiber 110, water, and an amine component, and obtaining the semipermeable composite membrane 100 by making the mixed solution be in contact with the porous support 102, thereafter, causing a cross-linking reaction of the amine component in the mixed solution, with the amine component adhering to the porous support 102.
B01D 63/10 - Modules à membranes enroulées en spirale
B01D 67/00 - Procédés spécialement adaptés à la fabrication de membranes semi-perméables destinées aux procédés ou aux appareils de séparation
B01D 69/02 - Membranes semi-perméables destinées aux procédés ou aux appareils de séparation, caractérisées par leur forme, leur structure ou leurs propriétésProcédés spécialement adaptés à leur fabrication caractérisées par leurs propriétés
B01D 69/10 - Membranes sur supportSupports pour membranes
B32B 27/06 - Produits stratifiés composés essentiellement de résine synthétique comme seul composant ou composant principal d'une couche adjacente à une autre couche d'une substance spécifique
B32B 27/28 - Produits stratifiés composés essentiellement de résine synthétique comprenant des copolymères de résines synthétiques non complètement couverts par les sous-groupes suivants
C02F 1/44 - Traitement de l'eau, des eaux résiduaires ou des eaux d'égout par dialyse, osmose ou osmose inverse
C02F 103/08 - Eau de mer, p. ex. pour le dessalement
48.
METHOD FOR PRODUCING TANTALUM NITRIDE MATERIAL, AND TANTALUM NITRIDE MATERIAL
A method for producing a tantalum nitride material that includes a nitriding step that heats a precursor containing a lithium tantalum composite oxide in the presence of a nitrogen compound.
Provided is a peptide which comprises no more than 25 amino acids and has an amino acid sequence of (i) or (ii). An amino acid sequence comprises the same citrulline as three or more citrullines in a partial sequence of SEQ ID NO: 1., with respect to (i) a partial sequence of a SEQ ID NO: 1 amino acid sequence, which is an amino acid sequence having eight or more continuous amino acids comprising one or more citrullines, and (ii) a partial sequence of SEQ ID NO: 1, which is an amino acid sequence having 13 or more continuous amino acids comprising one or more citrullines. Further, an amino acid sequence of ten or more remaining amino acids other than the one or more citrullines has at least 90% identity with an amino acid sequence of ten or more remaining amino acids other than the one or more citrullines among the partial sequence of SEQ ID NO: 1.
KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (Japon)
INTER-UNIVERSITY RESEARCH INSTITUTE CORPORATION NATIONAL INSTITUTES OF NATURAL SCIENCES (Japon)
OSAKA UNIVERSITY (Japon)
KYOTO UNIVERSITY (Japon)
SHINSHU UNIVERSITY (Japon)
Inventeur(s)
Nishida, Motohiro
Nishiyama, Kazuhiro
Kato, Yuri
Nishimura, Akiyuki
Nagata, Ryu
Mori, Yasuo
Nakagawa, Yasuaki
Kuwahara, Koichiro
Abrégé
Provided is a drug for preventing or treating heart failure, that is effective and that does not have a blood pressure lowering effect. The present invention pertains to: a pharmaceutical composition for preventing or treating heart failure or skeletal muscle failure, the pharmaceutical composition containing a TRPC3/6/7 channel activator; and a related screening method.
A61K 31/454 - Pipéridines non condensées, p. ex. pipérocaïne contenant d'autres systèmes hétérocycliques contenant un cycle à cinq chaînons avec l'azote comme hétéro-atome du cycle, p. ex. pimozide, dompéridone
A61K 31/495 - Composés hétérocycliques ayant l'azote comme hétéro-atome d'un cycle, p. ex. guanéthidine ou rifamycines ayant des cycles à six chaînons avec deux azote comme seuls hétéro-atomes d'un cycle, p. ex. pipérazine
A61K 31/496 - Pipérazines non condensées contenant d'autres hétérocycles, p. ex. rifampine, thiothixène ou sparfloxacine
A61P 9/04 - Agents inotropes, c.-à-d. stimulants de la contraction cardiaqueMédicaments pour le traitement de l'insuffisance cardiaque
A61P 21/00 - Médicaments pour le traitement des troubles du système musculaire ou neuromusculaire
C07D 401/00 - Composés hétérocycliques contenant plusieurs hétérocycles comportant des atomes d'azote comme uniques hétéro-atomes du cycle, au moins un cycle étant un cycle à six chaînons avec un unique atome d'azote
G01N 33/50 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique
51.
REAGENT FOR MEASURING FLUORINE ION CONCENTRATION, METHOD FOR MEASURING FLUORINE ION CONCENTRATION, AND DEVICE FOR MEASURING FLUORINE ION CONCENTRATION
Provided is a reagent for measuring fluorine ion concentration, which makes it possible to measure fluorine ion concentration by using visible light. The present invention provides a reagent for measuring fluorine ion concentration, including a metal organic framework and pigment molecules that can absorb visible light, wherein the pigment molecules are coordinate-bonded to the metal organic framework, and the reagent is composed such that when the reagent is mixed with an aqueous sample that may contain fluorine ions, the fluorine ions become coordinated with the metal in the metal organic framework, and the pigment molecules become released from the metal organic framework.
G01N 31/00 - Recherche ou analyse des matériaux non biologiques par l'emploi des procédés chimiques spécifiés dans les sous-groupesAppareils spécialement adaptés à de tels procédés
G01N 21/78 - Systèmes dans lesquels le matériau est soumis à une réaction chimique, le progrès ou le résultat de la réaction étant analysé en observant l'effet sur un réactif chimique produisant un changement de couleur
52.
CELL CULTURE MEMBER AND METHOD FOR MODIFYING SURFACE THEREOF
Provided are a cell culture member having excellent cell culture performance and its long-term stability, and a method for modifying the surface thereof. The cell culture member according to the present invention is a cell culture member having at least a holding region that holds an adherent cell and contains a polymer compound, wherein at least a part of the holding region is a surface-modified region in which a functional group containing a nitrogen atom is directly chemically bonded to a part of carbon atoms and/or silicon atoms constituting the polymer compound, and the present invention can provide a cell culture member that improves adhesiveness of the adherent cell to the surface-modified region, suppresses deterioration over time of adhesiveness, and is excellent in cell culture performance and its long-term stability.
Provided are a cell culture member having excellent cell culture performance and its long-term stability, and a method for modifying the surface thereof. The cell culture member according to the present invention is a cell culture member having at least a holding region that holds an adherent cell and contains a polymer compound, wherein at least a part of the holding region is a surface-modified region in which a fluorine atom is directly chemically bonded to a part of carbon atoms and/or silicon atoms constituting the polymer compound, and the present invention can provide a cell culture member that improves adhesiveness of the adherent cell to the surface-modified region, suppresses deterioration over time of adhesiveness, and is excellent in cell culture performance and its long-term stability.
C12N 5/00 - Cellules non différenciées humaines, animales ou végétales, p. ex. lignées cellulairesTissusLeur culture ou conservationMilieux de culture à cet effet
C12M 1/12 - Appareillage pour l'enzymologie ou la microbiologie avec des moyens de stérilisation, filtration ou dialyse
Provided is a method for operating a reverse osmosis membrane device which has a reverse osmosis membrane element and in which treated water is obtained by passing water to be treated that contains a scale component through the reverse osmosis membrane device, said method being characterized in that: the reverse membrane element includes a reverse osmosis membrane and a flow path member; a dense layer of the reverse osmosis membrane contains carbon nanotubes and cellulose nanofibers; the flow path member contains carbon nanotubes; and a scale dispersant is added to the water to be treated.
C02F 1/44 - Traitement de l'eau, des eaux résiduaires ou des eaux d'égout par dialyse, osmose ou osmose inverse
C02F 5/00 - Adoucissement de l'eauPrévention de l'entartrageAddition à l'eau d'agents antitartre ou détartrants, p. ex. addition d'agents séquestrants
C02F 5/08 - Traitement de l'eau avec des produits chimiques complexants ou des agents solubilisants pour l'adoucissement, la prévention ou l'élimination de l'entartrage, p. ex. par addition d'agents séquestrants
C02F 5/10 - Traitement de l'eau avec des produits chimiques complexants ou des agents solubilisants pour l'adoucissement, la prévention ou l'élimination de l'entartrage, p. ex. par addition d'agents séquestrants en utilisant des substances organiques
C02F 5/14 - Traitement de l'eau avec des produits chimiques complexants ou des agents solubilisants pour l'adoucissement, la prévention ou l'élimination de l'entartrage, p. ex. par addition d'agents séquestrants en utilisant des substances organiques contenant du phosphore
55.
COATED LITHIUM-TRANSITION METAL OXIDE PARTICLES, METHOD FOR PRODUCING SAME, POSITIVE ELECTRODE ACTIVE MATERIAL FOR LITHIUM ION BATTERY, AND LITHIUM ION BATTERY
The present invention improves input/output characteristics of a lithium ion battery. Coated lithium-transition metal oxide particles according to the present invention are obtained by at least partially coating the surfaces of lithium-transition metal oxide particles with a copolymer which is represented by formula (1) and which has a weight-average molecular weight of 200,000-600,000. The copolymer is cross-linked by ring opening of an oxetane ring. In formula (1), m and n each represent a number of 1 or greater. R1and R2each represent a hydrogen atom or a methyl group. R3represents an alkyl group having 1-5 carbon atoms. R4represents an alkanediyl group having 1-5 carbon atoms. R5 represents a hydrogen atom or an alkyl group having 1-5 carbon atoms.
H01M 4/525 - Emploi de substances spécifiées comme matériaux actifs, masses actives, liquides actifs d'oxydes ou d'hydroxydes inorganiques de nickel, de cobalt ou de fer d'oxydes ou d'hydroxydes mixtes contenant du fer, du cobalt ou du nickel pour insérer ou intercaler des métaux légers, p. ex. LiNiO2, LiCoO2 ou LiCoOxFy
H01M 4/36 - Emploi de substances spécifiées comme matériaux actifs, masses actives, liquides actifs
H01M 4/505 - Emploi de substances spécifiées comme matériaux actifs, masses actives, liquides actifs d'oxydes ou d'hydroxydes inorganiques de manganèse d'oxydes ou d'hydroxydes mixtes contenant du manganèse pour insérer ou intercaler des métaux légers, p. ex. LiMn2O4 ou LiMn2OxFy
56.
METHOD OF SEARCHING FOR SPECIFIC-BINDING FUNCTIONAL SUBSTANCES, SPECIFIC-BINDING FUNCTIONAL SUBSTANCE SEARCH SYSTEM, SPECIFIC-BINDING FUNCTIONAL SUBSTANCE SEARCH METHOD, AND PROGRAM
Destabilize a protein at least partially, provide the destabilized protein in a presence of a candidate functional substance, induce its restabilization, and determine the effect of a presence of the candidate functional substance in influencing a function of the protein, in order to search for functional substances that selectively bind to a non-native state of the protein and influence the function of the protein.
Provided are a particle two-dimensional acoustic focusing device that can efficiently focus and concentrate particles present in liquid flowing in a channel by using the acoustic effect of ultrasonic waves while having a simple configuration, and an acoustic concentration device using the particle two-dimensional acoustic focusing device. This particle two-dimensional acoustic focusing device is configured so as to focus particles contained in liquid flowing in a channel to the center of the cross-section of the channel by using ultrasonic waves and comprises: a rectangular channel 10 having a substantially rectangular cross-sectional shape when broken orthogonally to the extension direction of the channel; and a single ultrasonic wave generator 20 that simultaneously irradiates the interior of the rectangular channel 10 with a first ultrasonic wave and a second ultrasonic wave in a composite state, the first ultrasonic wave being generated so that the length of a long side a of the rectangle of the rectangular channel 10 is substantially equivalent to the length of a half wavelength, the second ultrasonic wave being generated so that the length of a short side b of the rectangle of the rectangular channel 10 is substantially equivalent to the length of the half wavelength.
B01D 43/00 - Séparation de particules de liquides, ou de liquides de solides, autrement que par sédimentation ou filtration
B01J 19/10 - Procédés utilisant l'application directe de l'énergie ondulatoire ou électrique, ou un rayonnement particulaireAppareils à cet usage utilisant des vibrations de fréquences audibles ou des ultrasons
G01N 37/00 - Détails non couverts par les autres groupes de la présente sous-classe
58.
CHIMERIC ANTIGEN RECEPTOR-EXPRESSING CELL THAT TARGETS EGFR
KYOTO PREFECTURAL PUBLIC UNIVERSITY CORPORATION (Japon)
Inventeur(s)
Nakazawa Yozo
Hirabayashi Koichi
Chinsuwan Thanyavi
Hasegawa Aiko
Yagyu Shigeki
Abrégé
The present invention addresses the problem of providing an EGFR CAR-T cell which is expected to be effective against a tumor in which an EGFR is expressed. The present invention provides: a polynucleotide encoding a chimeric antigen receptor (chimeric antigen receptor: CAR) protein comprising a target binding domain capable of binding to an epidermal growth factor receptor (EGFR), a transmembrane domain and an intracellular signaling domain, in which the target binding domain is a ligand of an EGFR; a vector carrying the polynucleotide; and a genetically modified cell into which the polypeptide or the vector has been introduced.
C12N 15/62 - Séquences d'ADN codant pour des protéines de fusion
A61K 35/12 - Substances provenant de mammifèresCompositions comprenant des tissus ou des cellules non spécifiésCompositions comprenant des cellules souches non embryonnairesCellules génétiquement modifiées
A61K 35/17 - LymphocytesLymphocytes BLymphocytes TCellules tueuses naturellesLymphocytes activés par un interféron ou une cytokine
A61K 48/00 - Préparations médicinales contenant du matériel génétique qui est introduit dans des cellules du corps vivant pour traiter des maladies génétiquesThérapie génique
A61P 1/00 - Médicaments pour le traitement des troubles du tractus alimentaire ou de l'appareil digestif
A61P 1/04 - Médicaments pour le traitement des troubles du tractus alimentaire ou de l'appareil digestif des ulcères, des gastrites ou des œsophagites par reflux, p. ex. antiacides, antisécrétoires, protecteurs de la muqueuse
A61P 1/16 - Médicaments pour le traitement des troubles du tractus alimentaire ou de l'appareil digestif des troubles de la vésicule biliaire ou du foie, p. ex. protecteurs hépatiques, cholagogues, cholélitholytiques
A61P 1/18 - Médicaments pour le traitement des troubles du tractus alimentaire ou de l'appareil digestif des troubles pancréatiques, p. ex. enzymes pancréatiques
A61P 11/00 - Médicaments pour le traitement des troubles du système respiratoire
A61P 15/00 - Médicaments pour le traitement des troubles génitaux ou sexuelsContraceptifs
A61P 17/00 - Médicaments pour le traitement des troubles dermatologiques
A61P 25/00 - Médicaments pour le traitement des troubles du système nerveux
Provided is a curved surface robot (1) comprising an actuator connecting body (5) configured by connecting a plurality of sheet-like actuators (2). Each of the sheet-like actuators (2) is deformed into a curved surface shape along a designated constant mean curvature curved surface, and thereby the actuator connecting body (5) is deformed into various curved surface shapes. Since a constant mean curvature curved surface can take an isothermal coordinate system, a base coordinate system set on the curved surface of the actuator connecting body (5) and a homogeneous transformation matrix orthogonal to each point on the curved surface can be considered, and conventional coordinate transformation of robotics can be applied as is. It is possible to realize a multi-degree-of-freedom curved surface robot (combination of robot and kinematics) that can express a complicated curved surface with a small number of parameters and can acquire a homogeneous transformation matrix on the robot more easily.
[Problem] To provide: a textile product which has an excellent ability to adsorb fouling substances and which can easily release the fouling substances that have been adsorbed; a method for producing a textile product; a method for regenerating a textile product; and a regenerant for a textile product. [Solution] This textile product comprises a fibrous base, a polymer layer fixed, by covalent bonding, to at least a part of the surface of the fibrous base, and a clay layer fixed to the surface of the polymer layer, wherein the polymer layer includes a polymer having a plurality of groups which can electrostatically fix the clay layer.
D06M 11/36 - Traitement des fibres, fils, filés, tissus ou des articles fibreux faits de ces matières, avec des substances inorganiques ou leurs complexesUn tel traitement combiné avec un traitement mécanique, p. ex. mercerisage avec de l'oxygène, de l'ozone, des ozonides, des oxydes, des hydroxydes ou des percomposésSels dérivés d'anions avec une liaison élément amphotère-oxygène avec des oxydes, des hydroxydes ou des oxydes mixtesTraitement des fibres, fils, filés, tissus ou des articles fibreux faits de ces matières, avec des substances inorganiques ou leurs complexesUn tel traitement combiné avec un traitement mécanique, p. ex. mercerisage avec de l'oxygène, de l'ozone, des ozonides, des oxydes, des hydroxydes ou des percomposésSels dérivés d'anions avec une liaison élément amphotère-oxygène avec des sels dérivés d'anions avec une liaison élément amphotère-oxygène
B32B 5/24 - Produits stratifiés caractérisés par l'hétérogénéité ou la structure physique d'une des couches caractérisés par la présence de plusieurs couches qui comportent des fibres, filaments, grains ou poudre, ou qui sont sous forme de mousse ou essentiellement poreuses une des couches étant fibreuse ou filamenteuse
B32B 9/04 - Produits stratifiés composés essentiellement d'une substance particulière non couverte par les groupes comprenant une telle substance comme seul composant ou composant principal d'une couche adjacente à une autre couche d'une substance spécifique
D06M 13/513 - Composés avec au moins une liaison carbone-métal ou carbone-bore, carbone-silicium, carbone-sélénium ou carbone-tellure avec au moins une liaison carbone-silicium
NATIONAL UNIVERSITY CORPORATION TOKAI NATIONAL HIGHER EDUCATION AND RESEARCH SYSTEM (Japon)
Inventeur(s)
Hiratsuka Sachie
Tomita Takeshi
Hayashi Hikaru
Ueno Yoshihito
Chano Tokuhiro
Furuichi Yasuhiro
Kawade Miwa
Kakizawa Yuri
Abrégé
This antitumor agent comprises, as an active ingredient, an RNA which has a base sequence selected from the group consisting of the following (1) and (2) and has at least one nucleotide unit represented by formula (1) in a 3'-terminal region within 20 bases from the 3'-terminal thereof and/or in a 5'-terminal region within 25 bases from the 5'-terminal thereof. (1) A base sequence represented by SEQ ID NO: 2 or a base sequence having at least 90% identity with the sequence, and (2) a base sequence having 20 to 200 consecutive bases among the base sequences of (1) above (in formula (1), R1represents a hydroxyl group, a hydroxyl group in which a hydrogen atom is substituted with an alkyl group or an alkenyl group, or a halogen atom; R2represents NHR3having a linking group, and the linking group is a divalent hydrocarbon group having at least one carbon atom; R3represents a hydrogen atom, an alkyl group, or an alkenyl group; n represents 0 or 1; X1represents an oxygen atom or a sulfur atom; X2represents OH (or O-) or SH (or S-); and B represents a purine base or a pyrimidine base.)
A61K 48/00 - Préparations médicinales contenant du matériel génétique qui est introduit dans des cellules du corps vivant pour traiter des maladies génétiquesThérapie génique
An intermediate according to one embodiment of the present invention contains a rubber component, carboxyl group-containing cellulose nanofibers, and a trivalent or higher cation. The cellulose nanofibers include nanofibers derived from oxidized cellulose that has been oxidized using an N-oxyl compound. In addition, an intermediate according to one embodiment of the present invention contains a rubber component, carboxyl group-containing cellulose nanofibers, and an unsaturated carboxylic acid salt containing a monovalent metal ion and/or a polymer having a repeating unit derived from an unsaturated carboxylic acid salt containing a monovalent metal ion. The cellulose nanofibers include nanofibers derived from oxidized cellulose that has been oxidized using an N-oxyl compound.
An intermediate comprising a first rubber component, a nanocellulose, and a cation having a valence of three or more, wherein the nanocellulose is derived from an oxide of a cellulose-based material obtained by means of hypochlorite or a salt thereof, and is not derived from an oxide of a cellulose-based material obtained by means of an N-oxyl compound. An intermediate comprising a first rubber component, a nanocellulose, and a polymer having a repeating unit derived from an unsaturated carboxylate including a monovalent metal ion and/or an unsaturated carboxylate including a monovalent metal ion, wherein the nanocellulose is derived from an oxide of a cellulose-based material obtained by means of hypochlorite or a salt thereof, and is not derived from an oxide of a cellulose-based material obtained by means of an N-oxyl compound.
C08L 21/00 - Compositions contenant des caoutchoucs non spécifiés
C08J 3/20 - Formation de mélanges de polymères avec des additifs, p. ex. coloration
C08L 1/00 - Compositions contenant de la cellulose, de la cellulose modifiée ou des dérivés de la cellulose
C08L 101/08 - Compositions contenant des composés macromoléculaires non spécifiés caractérisées par la présence de groupes déterminés contenant des atomes d'oxygène des groupes carboxyle
64.
THREE-DIMENSIONAL DATA SCALE SETTING METHOD AND THREE-DIMENSIONAL DATA SCALE SETTING PROGRAM
To set a scale for three dimensional data composed from point cloud data: a plurality of reference objects (22) of sizes and shapes known in advance are disposed around an object (20) under measurement; image data or position data obtained by imaging the object (20) under measurement together with the plurality of reference objects (22) from various angles is input to a computer (30); the known sizes and shapes of the reference objects (22) are input to the computer (30); and the computer (30) acquires point cloud data for the object (20) under measurement and each reference object (22) from a plurality of pieces of the image data or a plurality of pieces of the position data, determines, as reference objects, objects in the point cloud data having sizes and shapes within prescribed error ranges with respect to the sizes and shapes input for the reference objects (22), and sets the overall scale of the point cloud data by extending/contracting and/or twisting the point cloud data such that each of the determined reference objects has the input size and shape.
Provided is a chain transfer agent that is a chain transfer agent other than a mercaptan compound and can sufficiently control molecular weight. The present invention provides a chain transfer agent represented by formula (1). [In formula (1): X is a group selected from among a cyano group, an optionally substituted aryl group, an acyl group, a carboxy group, COOR122, C(O)NHR1, C(O)NR122, SOR122R133R1and OR1; Y and Z are each a group selected from among a cyano group, an optionally substituted aryl group, an acyl group a carboxy group, COOR122, C(O)NHR1, C(O)NR122, SOR122R133R1, OR1, OC(O)R1, N(H)C(O)R1and a halogen, or Y and Z are bonded together to form an optionally substituted carbocyclic structure or an optionally substituted heterocyclic structure; X, Y and Z may be either the same or different; R1is an optionally substituted alkyl group having 1-8 carbon atoms; Q is hydrogen, an optionally substituted alkyl group having 1-6 carbon atoms or a phenyl group; R2and R3are hydrogen or a group selected from among an alkyl group having 2-6 carbon atoms, an optionally substituted aryl group and an optionally substituted heterocyclic structure; and R2and R3may be either the same or different (except when R2and R3 are both hydrogen).]
C08F 2/38 - Polymérisation utilisant des régulateurs, p. ex. des agents d'arrêt de chaîne
C08F 20/18 - Esters des alcools ou des phénols monohydriques des phénols ou des alcools contenant plusieurs atomes de carbone avec l'acide acrylique ou l'acide méthacrylique
Provided is a detection device with which it is possible to detect oral microbes in a highly accurate manner. This detection device has: a container for accommodating a sample containing contaminants in the oral cavity and composite particles in which a fluorescent labelling substance is bound to oral microbes; a radiation unit for radiating, into the container, excitation light for exciting the fluorescent labelling substance of the composite particles; a light detection unit for detecting light from the container in a state in which the fluorescent labelling substance is excited; and a detection unit for optically detecting the composite particles in the container on the basis of the result of the detection by the light detection unit, the excitation light being light in the wavelength band of 550 nm or above with which excitation of the contaminants is minimized.
G01N 33/483 - Analyse physique de matériau biologique
G01N 33/50 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique
67.
CONNECTION STRUCTURAL BODY AND SEMICONDUCTOR DEVICE
A connection structural body includes: a first connection terminal including a first opposing surface; a first roughened-surface copper metal film formed on the first opposing surface; a second connection terminal including a second opposing surface facing the first opposing surface; and a second roughened-surface copper metal film formed on the second opposing surface and bonded to the first roughened-surface copper metal film. The first roughened-surface copper metal film includes a structure in which first deposits of copper are piled over one another on the first opposing surface. The second roughened-surface copper metal film includes a structure in which second deposits of copper are piled over one another on the second opposing surface. A bonded portion of the first and second roughened-surface copper metal films includes a structure in which the first deposits and the second deposits are piled such that the bonded portion includes pores.
This free-range livestock management server device: acquires information pertaining to individuals or locations; identifies individuals on the basis of the acquired information; identifies locations on the basis of the acquired information; ascertains states of the individuals or locations on the basis of the acquired information; monitors for an abnormal state of the individuals or locations on the basis of the acquired information; organizes, for each individual or location that has been identified, information pertaining to the identified individuals or locations, ascertained states, and monitored abnormal state, and thereby associates such information with each individual or location that has been identified; stores the organized and associated information; determines, out of the stored information, the urgency of information pertaining to the abnormal state of the individuals or locations, such determination being on the basis of a preset criterion; and generates notice information on the basis of information determined to be urgent and transmit same to a predetermined terminal.
Kyoto Prefectural Public University Corporation (Japon)
Inventeur(s)
Hosoi, Hajime
Iehara, Tomoko
Yagyu, Shigeki
Nakazawa, Yozo
Abrégé
An object of the present invention is to provide a therapeutic strategy in the solid tumor area and a means useful therefor to further advance the clinical application of CAR therapy. There is prepared a gene-modified lymphocyte which expresses a chimeric antigen receptor having an EphrinB2 extracellular domain at the antigen recognition site.
C07K 14/705 - RécepteursAntigènes de surface cellulaireDéterminants de surface cellulaire
70.
NEGATIVE ELECTRODE ACTIVE MATERIAL FOR SECONDARY BATTERY AND METHOD FOR PRODUCING SAME, NEGATIVE ELECTRODE FOR SECONDARY BATTERY, AND SECONDARY BATTERY
A negative electrode active material (102) for a secondary battery according to the present invention comprises: active material particles (106) which contain a self-assembled monolayer film 104 having a silicon composite body (103) and an amino group that covers the surface of the silicon composite body (103); and a binder (105) which is bonded to the self-assembled monolayer film 104 via the amino group. The binder (105) comprises first carbon nanotubes having a length of not more than 1000 nm, and second carbon nanotubes having a length of not less than 2 μm.
[Problem] To provide a cell culture substrate, a cell culture container and an adherent cell detachment method, whereby adherent cells can be more simply detached compared with the case of using trypsin. [Solution] A cell culture substrate to be used for coating a cell culture container, said cell culture substrate containing, as an active ingredient, at least one protein selected from among silk protein, a hydrolysate of silk protein, fibroin and a hydrolysate of fibroin.
[Problem] To enable management of health in consideration of individual differences. [Solution] An information processing system according to the present invention comprises a measurement storage unit that stores a measurement linked to the achievement goals of a user, an intake storage unit that stores the intake of a plurality of nutrients taken by the user, an analysis unit that analyzes a relationship between the intake of nutrients and the measurement to specify an improvement factor that is a nutrient contributing to improvement of the measurement and a deterioration factor that is a nutrient contributing to deterioration of the measurement, a meal menu storage unit that stores information specifying content of nutrients contained in the meal menu, and a meal menu proposition unit that modifies the meal menu by increasing the content of the improvement factor and/or decreasing the content of the deterioration factor, and proposes the modified meal menu.
G16H 20/60 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant le contrôle de l’alimentation, p. ex. les régimes
73.
SINGLE CRYSTALLINE TA3N5 NANOPARTICLES MODIFIED WITH A MOX COCATALYST, A CATALYST, METHODS FOR WATER SPLITTING USING THE CATALYST, AND METHODS TO MAKE SAME
353535x22, is disclosed. The nanoparticles can further be modified to include a water reducing catalyst. A water splitting catalyst is further disclosed. Methods of making the nanoparticles and catalyst are also disclosed. Methods to split water utilizing the catalyst are further described.
The present invention addresses the problem of providing an aerosol composition that does not substantially contain a surfactant and has good dispersion stability even when an oily component is contained in a large amount. This problem is solved by an aerosol composition containing water, an oily component, and a water-soluble polymer, wherein the water-soluble polymer contains at least one selected from the group consisting of polyvinyl alcohol and polyvinyl pyrrolidone, the content of the water-soluble polymer in the aerosol composition is 0.01-2.5 mass%, the aerosol composition forms an emulsion, the average particle size of the droplets of the emulsion is 0.5-7.0 μm, and the aerosol composition does not substantially contain a surfactant.
A61K 8/81 - Cosmétiques ou préparations similaires pour la toilette caractérisés par la composition contenant des composés organiques macromoléculaires obtenus par des réactions faisant intervenir uniquement des liaisons insaturées carbone-carbone
A61K 8/92 - Huiles, graisses ou ciresLeurs dérivés, p. ex. produits d'hydrogénation
B01J 13/00 - Chimie des colloïdes, p. ex. production de substances colloïdales ou de leurs solutions, non prévue ailleursFabrication de microcapsules ou de microbilles
This invention provides a fiber melt spinning method that uses a 3D printer. The objective of this invention is to provide a spinning method that is very useful for the production of fibers endowed with shape memory and other desired functionalities.
D01F 6/70 - Filaments, ou similaires, faits par l’homme, à un seul composant, formés de polymères synthétiquesLeur fabrication à partir de produits d'homopolycondensation à partir de polyuréthanes
76.
CELLS EXPRESSING PRE-PRO-PRECURSOR FORM CHIMERIC ANTIGEN RECEPTOR TARGETING IGF1R
Provided is an IGF1R CAR-T cell that is expected to be effective against tumors that express IGF1R. Provided is a polynucleotide that encodes a chimeric antigen receptor (CAR) protein having a target-binding domain that binds to the insulin-like growth factor-1 receptor (IGF1R), a transmembrane domain, and an intracellular signaling domain, wherein the target-binding domain is the pre-pro-precursor for insulin-like growth factor (IGF) or its E-domain-deleted fragment. Also provided are a vector containing this polynucleotide and genetically modified cells into which this polypeptide or vector has been introduced.
Provided are a textile product capable of firmly fixing a functional material onto the surface thereof and having excellent washing durability, and a method for producing the textile product, being capable of efficiently producing the textile product. Provided is a textile product including: a textile base material; a surface treatment layer formed of a silane coupling agent on at least a part of the surface of the textile base material; and a zirconium phosphate layer fixed on the surface treatment layer, wherein the silane coupling agent includes a silane compound having an amino group.
D06M 13/513 - Composés avec au moins une liaison carbone-métal ou carbone-bore, carbone-silicium, carbone-sélénium ou carbone-tellure avec au moins une liaison carbone-silicium
A positive electrode according to the present invention is a positive electrode of a lithium ion secondary battery in which a coating film containing a positive electrode active material is pressed against a surface of a positive electrode base material, and the positive electrode active material is a mixture of a first active material containing single particles of lithium composite oxide and a second active material containing secondary particles which are aggregated single particles of lithium composite oxide.
H01M 4/36 - Emploi de substances spécifiées comme matériaux actifs, masses actives, liquides actifs
H01M 10/0525 - Batteries du type "rocking chair" ou "fauteuil à bascule", p. ex. batteries à insertion ou intercalation de lithium dans les deux électrodesBatteries à l'ion lithium
H01M 4/131 - Électrodes à base d'oxydes ou d'hydroxydes mixtes, ou de mélanges d'oxydes ou d'hydroxydes, p. ex. LiCoOx
H01M 4/525 - Emploi de substances spécifiées comme matériaux actifs, masses actives, liquides actifs d'oxydes ou d'hydroxydes inorganiques de nickel, de cobalt ou de fer d'oxydes ou d'hydroxydes mixtes contenant du fer, du cobalt ou du nickel pour insérer ou intercaler des métaux légers, p. ex. LiNiO2, LiCoO2 ou LiCoOxFy
H01M 4/505 - Emploi de substances spécifiées comme matériaux actifs, masses actives, liquides actifs d'oxydes ou d'hydroxydes inorganiques de manganèse d'oxydes ou d'hydroxydes mixtes contenant du manganèse pour insérer ou intercaler des métaux légers, p. ex. LiMn2O4 ou LiMn2OxFy
79.
PHARMACEUTICAL COMPOSITION FOR PREVENTING AND/OR TREATING HEART FAILURE
The present invention addresses the problem of providing a pharmaceutical composition for preventing and/or treating heart failure. The present invention pertains to a pharmaceutical composition or the like that is for preventing and/or treating heart failure and that contains: a compound represented by general formula (1) [in the formula, A represents an optionally substituted benzene ring, B represents an optionally substituted aryl or an optionally substituted heteroaryl, X represents an oxygen atom or a sulfur atom, Y represents a nitrogen atom or a carbon atom, each R1independently represents a lower alkyl, two R1s may be bound to each other to form a spiro ring or a crosslinked structure, or two R1s may be bound to each other to form, together with a nitrogen atom and a carbon atom forming a ring including Y, a saturated fused heterocyclic ring, and p represents 0, 1, or 2, or (R1pp represents oxo]; a salt thereof; or a prodrug thereof.
A61K 31/4439 - Pyridines non condenséesLeurs dérivés hydrogénés contenant d'autres systèmes hétérocycliques contenant un cycle à cinq chaînons avec l'azote comme hétéro-atome du cycle, p. ex. oméprazole
A61K 31/4418 - Pyridines non condenséesLeurs dérivés hydrogénés ayant un carbocycle lié directement à l'hétérocycle, p. ex. cyproheptadine
A61K 31/454 - Pipéridines non condensées, p. ex. pipérocaïne contenant d'autres systèmes hétérocycliques contenant un cycle à cinq chaînons avec l'azote comme hétéro-atome du cycle, p. ex. pimozide, dompéridone
A61K 31/4545 - Pipéridines non condensées, p. ex. pipérocaïne contenant d'autres systèmes hétérocycliques contenant un cycle à six chaînons avec l'azote comme hétéro-atome du cycle, p. ex. pipampérone, anabasine
A61K 31/495 - Composés hétérocycliques ayant l'azote comme hétéro-atome d'un cycle, p. ex. guanéthidine ou rifamycines ayant des cycles à six chaînons avec deux azote comme seuls hétéro-atomes d'un cycle, p. ex. pipérazine
A61K 31/496 - Pipérazines non condensées contenant d'autres hétérocycles, p. ex. rifampine, thiothixène ou sparfloxacine
A61K 31/5377 - 1,4-Oxazines, p. ex. morpholine non condensées et contenant d'autres hétérocycles, p. ex. timolol
A61K 31/55 - Composés hétérocycliques ayant l'azote comme hétéro-atome d'un cycle, p. ex. guanéthidine ou rifamycines ayant des cycles à sept chaînons, p. ex. azélastine, pentylènetétrazole
A61P 9/04 - Agents inotropes, c.-à-d. stimulants de la contraction cardiaqueMédicaments pour le traitement de l'insuffisance cardiaque
80.
LAYERED PLATINATE, LAYERED PLATINIC ACID, PLATINIC ACID NANOSHEET, PLATINUM NANOSHEET AND PRODUCTION METHOD THEREOF
xyz2xyz22O overlapping in layers; a platinic acid nanosheet having a thickness of 1 nm or less; and a platinum nanosheet having a thickness of 0.6 nm or less.
Provided are a ruminant feed composition that can be easily manufactured and is capable of reducing the amount of methane gas produced in the body, a ruminant feed and a method for manufacturing a ruminant feed composition. The method for manufacturing a ruminant feed composition according to the present invention comprises: a step for housing a persimmon material in a sealed space; a step for heating the sealed space; a step for heating and pressurizing the persimmon material by water vapor in the sealed space for 2-5 hours under a temperature of 120-134°C to decompose the material; and a step for cooling the sealed space. In the step for heating the sealed space, the sealed space is heated while allowing the water vapor pressure in the sealed space to follow the saturated water vapor pressure curve. In the step for cooling the sealed space, the sealed space is cooled while allowing the water vapor pressure in the sealed space to follow the saturated water vapor pressure curve.
A23K 10/37 - Produits alimentaires pour animaux à base de matières d’origine végétale, p. ex. de racines, de graines ou de foinProduits alimentaires pour animaux à base de matières d’origine fongique, p. ex. de champignons à base de matières résiduelles
A23K 50/10 - Produits alimentaires spécialement conçus pour des animaux spécifiques pour les ruminants
82.
PHOTOCATALYST PRODUCTION METHOD, AND HYDROGEN AND OXYGEN PRODUCTION METHOD USING SAID PHOTOCATALYST
JAPAN TECHNOLOGICAL RESEARCH ASSOCIATION OF ARTIFICIAL PHOTOSYNTHETIC CHEMICAL PROCESS (Japon)
Inventeur(s)
Yoshida, Hiroaki
Tsutsuminai, Susumu
Kariya, Nobuko
Domen, Kazunari
Hisatomi, Takashi
Lin, Lihua
Tao, Xiaoping
Liang, Xizhuang
Abrégé
abcdd ... (I) (where M is one element or a combination of two or more elements selected from among Pr, Nd, Pm, Sm, Eu, Gd, Tb, Dy, Ho, Er, Tm, and Y, a=1.7-2.3, b=2, c=4.7-5.3, and d=1.7-2.3.)
C25B 9/00 - Cellules ou assemblages de cellulesÉléments de structure des cellulesAssemblages d'éléments de structure, p. ex. assemblages d'électrode-diaphragmeCaractéristiques des cellules relatives aux procédés
C25B 9/50 - Cellules ou assemblages de cellules comprenant des photo-électrodesAssemblages de leurs éléments de structure
C25B 11/093 - Électrodes comportant des électro-catalyseurs sur un substrat ou un support caractérisées par le matériau électro-catalytique formé d’au moins un élément catalytique et d’au moins un composé catalytiqueÉlectrodes comportant des électro-catalyseurs sur un substrat ou un support caractérisées par le matériau électro-catalytique formé de plusieurs éléments catalytiques ou composés catalytiques au moins un métal noble ou oxyde de métal noble et au moins un oxyde d’un métal non noble
2222 is preferably within the range of 1-26% inclusive, and Pt:Ir (atomic ratio) constituting the composite catalyst is preferably within the range of 1.5:1-50:1.
KYOTO PREFECTURAL PUBLIC UNIVERSITY CORPORATION (Japon)
SHINSHU UNIVERSITY (Japon)
Inventeur(s)
Kishimoto, Megumi
Shimizu, Yuto
Kubota, Susumu
Yagyu, Shigeki
Suematsu, Masaya
Nakazawa, Yozo
Tanaka, Miyuki
Abrégé
The present invention provides a method for producing chimeric antigen receptor T (CAR-T) cells, the method comprising a step for isolating, by means of beads, T cells from a T cell supply source using a specific factor. The specific factor is CD45RA+ or the like. The method enables production of CAR-T cells having high anti-tumor activity, and enables production of highly-functional CAR-T cells easily in a short period of time at a low cost.
[Problem] To provide a method for producing a dielectric film using a polymeric material and an organic compound having a polar group. [Solution] A method for producing a dielectric film, comprising a step in which a polymeric material and an organic compound having a polar group are dissolved in a solvent to prepare a mixture solution including the polymeric material and the organic compound having a polar group, a step in which the mixture solution is applied to a substrate, and a step in which the polymeric material applied to the substrate is cured to form a thin film, the method being characterized in that the mixture solution is prepared so that the cured thin film has an inner structure composed of separated phases which are a continuous phase comprising the polymeric material and a dispersed phase consisting mainly of the organic compound having a polar group.
C08L 101/00 - Compositions contenant des composés macromoléculaires non spécifiés
H01B 3/28 - Isolateurs ou corps isolants caractérisés par le matériau isolantEmploi de matériaux spécifiés pour leurs propriétés isolantes ou diélectriques composés principalement de substances organiques caoutchoucs naturels ou synthétiques
B60L 50/60 - Propulsion électrique par source d'énergie intérieure au véhicule utilisant de la puissance de propulsion fournie par des batteries ou des piles à combustible utilisant de l'énergie fournie par des batteries
C08K 3/11 - Composés contenant des métaux des groupes 4 à 10 ou des groupes 14 à 16 du tableau périodique
H02M 7/5387 - Transformation d'une puissance d'entrée en courant continu en une puissance de sortie en courant alternatif sans possibilité de réversibilité par convertisseurs statiques utilisant des tubes à décharge avec électrode de commande ou des dispositifs à semi-conducteurs avec électrode de commande utilisant des dispositifs du type triode ou transistor exigeant l'application continue d'un signal de commande utilisant uniquement des dispositifs à semi-conducteurs, p. ex. onduleurs à impulsions à un seul commutateur dans une configuration en pont
H02P 27/06 - Dispositions ou procédés pour la commande de moteurs à courant alternatif caractérisés par le type de tension d'alimentation utilisant une tension d’alimentation à fréquence variable, p. ex. tension d’alimentation d’onduleurs ou de convertisseurs utilisant des convertisseurs de courant continu en courant alternatif ou des onduleurs
A method for regenerating a lithium composite oxide, which is an active material of a deteriorated lithium ion secondary battery, comprising: a step in which a lithium composite oxide is recovered from a deteriorated lithium ion secondary battery; and a step in which the recovered lithium composite oxide is mixed with a lithium source and a flux source so that the crystal of the lithium composite oxide is grown by a flux method.
Disclosed is a top layer for a light absorption surface, which comprises a matrix and nanoparticles embedded therein. The top layer may constitute the outermost layer of a solar absorber coating or absorber material surface, for use in solar heat power generation. The top layer may be able to enhance light absorption and accommodate the thermal expansion/contraction of the absorption coating or that of its underlying substrate in use. The nanoparticles embedded in, or adhered to the matrix, may contribute to the light absorption of the underlying absorption surface.
F24S 70/20 - Détails des éléments absorbeurs caractérisés par des revêtements absorbeursDétails des éléments absorbeurs caractérisés par un traitement de surface pour accroître l’absorption
F24S 70/30 - Revêtements auxiliaires, p. ex. revêtements anti-réfléchissants
F24S 70/60 - Détails des éléments absorbeurs caractérisés par la structure ou la construction
91.
Composition For Improving Mental State, Production Method For Composition For Improving Mental State, And Use Of Fruit Of Eggplant For Improving Mental State
The present invention addresses the problem of providing a novel composition having the effect of improving a mental state. The present invention pertains to: a composition that is for improving a mental state, and that contains, as an active ingredient, a water-soluble component of the fruit of eggplant (Solanum melongena); and a production method that is for an eggplant-derived composition for improving a mental state, and that comprises squeezing an eggplant fruit to obtain a juice, or adding water to an eggplant fruit and squeezing the fruit to which water has been added, to obtain a juice.
The present invention provides nanometer-sized fibers that are produced by an electrospinning method with use of a spinning solution for electrospinning, said spinning solution being environmentally friendly and taking the effects of an organic solvent on the human body into consideration. The fibers are formed from a resin that contains a silicone-modified polyurethane resin which is a reaction product of (A) a polyol, (B) a water dispersant, (C) an active hydrogen group-containing organopolysiloxane represented by formula (1)
The present invention provides nanometer-sized fibers that are produced by an electrospinning method with use of a spinning solution for electrospinning, said spinning solution being environmentally friendly and taking the effects of an organic solvent on the human body into consideration. The fibers are formed from a resin that contains a silicone-modified polyurethane resin which is a reaction product of (A) a polyol, (B) a water dispersant, (C) an active hydrogen group-containing organopolysiloxane represented by formula (1)
R1R2R3SiO(SiR2R3O)nSiR1R2R3 (1)
The present invention provides nanometer-sized fibers that are produced by an electrospinning method with use of a spinning solution for electrospinning, said spinning solution being environmentally friendly and taking the effects of an organic solvent on the human body into consideration. The fibers are formed from a resin that contains a silicone-modified polyurethane resin which is a reaction product of (A) a polyol, (B) a water dispersant, (C) an active hydrogen group-containing organopolysiloxane represented by formula (1)
R1R2R3SiO(SiR2R3O)nSiR1R2R3 (1)
(wherein R1 represents a monovalent hydrocarbon group which may have an oxygen atom in the chain, while having from 1 to 10 carbon atoms and a hydroxyl group or a mercapto group, or a monovalent hydrocarbon group which has a primary amino group or a secondary amino group, while having from 1 to 10 carbon atoms; each of R2 and R3 represents a group that is selected from among an alkyl group having from 1 to 10 carbon atoms, an aralkyl group having from 7 to 10 carbon atoms, an aryl group having from 6 to 12 carbon atoms and a vinyl group; and n represents an integer from 1 to 200), and (D) a polyisocyanate.
C08G 18/77 - Polyisocyanates ou polyisothiocyanates contenant des hétéro-atomes autres que l'azote, l'oxygène ou le soufre de l'isocyanate ou de l'isothiocyanate
D01F 6/70 - Filaments, ou similaires, faits par l’homme, à un seul composant, formés de polymères synthétiquesLeur fabrication à partir de produits d'homopolycondensation à partir de polyuréthanes
D01D 5/00 - Formation des filaments, fils ou similaires
D04H 1/728 - Non-tissés formés uniquement ou principalement de fibres coupées ou autres fibres similaires relativement courtes caractérisés par la méthode de formation des voiles ou couches, p. ex. par la réorientation des fibres les fibres étant disposées au hasard par électrofilage
93.
DETERMINATION DEVICE, DETERMINATION METHOD, AND PROGRAM
A determination device 1 is provided with: an acquisition unit 21 for acquiring digital color image data 11 about a region of interest in melanonychia striata in a subject; a calculation unit 23 for calculating an index value 12 from the variation in RGB values of the individual pixels in the digital color image data 11; and an output unit 24 for outputting such a result that the melanonychia striata is determined as malignant when the index value 12 is larger than a threshold value and the melanonychia striata is determined as benign when the index value 12 is smaller than the threshold value.
A61B 10/00 - Instruments pour le prélèvement d'échantillons corporels à des fins de diagnostic Autres procédés ou instruments pour le diagnostic, p. ex. pour le diagnostic de vaccination ou la détermination du sexe ou de la période d'ovulationInstruments pour gratter la gorge
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
94.
METHOD FOR PRODUCING HEXAGONAL BORON NITRIDE POWDER, AND HEXAGONAL BORON NITRIDE POWDER
Provided is a production method which makes it possible to improve a filling property, with respect to a resin, of a hexagonal boron nitride powder which contains hexagonal boron nitride particles each having a low aspect ratio, while maintaining low thermal conduction anisotropy of the hexagonal boron nitride powder. A method of producing a hexagonal boron nitride powder includes disintegrating, by a means which substantially does not involve pulverization of primary particles, a hexagonal boron nitride raw material powder which contains (i) hexagonal boron nitride particles each having an aspect ratio of 1.5 to 5.0 and (ii) an aggregate that contains hexagonal boron nitride particles each having an aspect ratio of more than 5.0.
A surface-treated nanocellulose master batch includes a rubber component, a nanocellulose, a resole or novolac resorcin-formaldehyde initial condensation product, and formaldehyde. The the surface-treated nanocellulose master batch includes from 0.3 to 15 parts by mass of the nanocellulose per 100 parts by mass of the rubber component. The the surface-treated nanocellulose master batch includes from 0.03 to 1.2 parts by mass of the resole or novolac resorcin-formaldehyde initial condensation product per 1 part by mass of the nanocellulose and 0.02 to 0.8 parts by mass of the formaldehyde per 1 part by mass of the nanocellulose.
Single crystalline nanoparticles that are tantalum nitride doped with at least one metal are described. The single crystalline nanoparticles can be doped with two metals such as Zr and Mg. The single crystalline nanoparticles can be TasNsMg+Zr, or TasNsMg, or TasNs:Zr or any combination thereof. Catalyst containing the single crystalline nanoparticles alone or with one or more co-catalyst are further described along with methods of making the nanoparticles and catalyst. Methods to split water utilizing the catalyst are further described.
Provided is a nanocellulose master batch that can be used to obtain a rubber composition in which nanocellulose is homogenously dispersed and which has excellent tensile stress and stretchability. This nanocellulose master batch contains a rubber component, a nanocellulose that is surface-treated with at least one selected from the group consisting of phenolic resins, epoxy resins, urethane resins, and melamine resins, and a water-soluble polymer. In the nanocellulose master batch, the nanocellulose is contained in an amount of 0.3-15 parts by mass with respect to 100 parts by mass of the rubber component, and the water-soluble polymer is contained in an amount of 0.03-1.2 parts by mass with respect to 1 part by mass of the nanocellulose.
C08K 9/04 - Ingrédients traités par des substances organiques
C08L 1/00 - Compositions contenant de la cellulose, de la cellulose modifiée ou des dérivés de la cellulose
C08L 101/14 - Compositions contenant des composés macromoléculaires non spécifiés caractérisées par des propriétés physiques, p. ex. anisotropie, viscosité ou conductivité électrique les composés macromoléculaires étant solubles dans l'eau ou gonflables dans l'eau, p. ex. gels aqueux
98.
Layered Double Hydroxide Crystal, Anion Adsorbent, and Method for Producing Layered Double Hydroxide Crystal
What is provided is a layered double hydroxide crystal for achieving higher ion-exchange capacity than that of the related art.
What is provided is a layered double hydroxide crystal for achieving higher ion-exchange capacity than that of the related art.
The layered double hydroxide crystal 1 according to the present embodiment is represented by Formula (1) and composed of a plurality of crystal grains 10 each of which has a lamination structure in which a plurality of plate-shaped crystals (11), (11), . . . are laminated, in which particle sizes of the plurality of crystal grains (10), (10), . . . are uniform on a microscale.
What is provided is a layered double hydroxide crystal for achieving higher ion-exchange capacity than that of the related art.
The layered double hydroxide crystal 1 according to the present embodiment is represented by Formula (1) and composed of a plurality of crystal grains 10 each of which has a lamination structure in which a plurality of plate-shaped crystals (11), (11), . . . are laminated, in which particle sizes of the plurality of crystal grains (10), (10), . . . are uniform on a microscale.
[Ni2+1-xFe3+x(OH)2].[(Cl−)X/2] (1)
(Where, 0.25
This carbon nanotube structure, in which a plurality of carbon nanotubes are assembled, has: joining portions between end portions and end portions of the carbon nanotubes; and joining portions between end portions and side wall portions of the carbon nanotubes.
C02F 1/28 - Traitement de l'eau, des eaux résiduaires ou des eaux d'égout par absorption ou adsorption
C02F 1/42 - Traitement de l'eau, des eaux résiduaires ou des eaux d'égout par échange d'ions
B01J 20/06 - Compositions absorbantes ou adsorbantes solides ou compositions facilitant la filtrationAbsorbants ou adsorbants pour la chromatographieProcédés pour leur préparation, régénération ou réactivation contenant une substance inorganique contenant des oxydes ou des hydroxydes des métaux non prévus dans le groupe
B01J 20/20 - Compositions absorbantes ou adsorbantes solides ou compositions facilitant la filtrationAbsorbants ou adsorbants pour la chromatographieProcédés pour leur préparation, régénération ou réactivation contenant une substance inorganique contenant du carbone libreCompositions absorbantes ou adsorbantes solides ou compositions facilitant la filtrationAbsorbants ou adsorbants pour la chromatographieProcédés pour leur préparation, régénération ou réactivation contenant une substance inorganique contenant du carbone obtenu par des procédés de carbonisation
B01J 20/30 - Procédés de préparation, de régénération ou de réactivation
brevets
